Robeco Institutional Asset Management’s Revolution Medicines RVMD Stock Holding History

Robeco Institutional Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$775K	Buy	+4,140	New	+$605K	﹤0.01%	746

Other funds holding RVMD

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Robeco Institutional Asset Management's RVMD Position: Q2 2026 in Review

Robeco Institutional Asset Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 4,140 shares worth $775K. The stake represents ﹤0.01% of the portfolio and ranks #746 among its holdings.

184 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Robeco Institutional Asset Management held 4,140 shares of Revolution Medicines worth $775K as of Q2 2026.
Revolution Medicines was a new Robeco Institutional Asset Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #746 holding.
184 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.